Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. Since the passing of ...
Unfortunately, it leaves out an important evidence-based therapy option: electrical spinal cord stimulation (SCS ... the usual trial period for other pain disorders can be omitted for this ...
The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...